Merck Open to Indie Review on Possibly Carcinogenic Januvia

In response to concerns that Merck’s $5.7 billion diabetes drug Januvia could be carcinogenic…

“Merck said in a statement today it’s willing to participate in an independent review of data called for by the American Diabetes Association.”

The full story here:

bloomberg.com/news/2013-06-1 … drugs.html

In all fairness, Merck is to be applauded.

Now let’s hope they see the light on the finasteride front and embrace third-party clinical studies seeking to determine the root causes of post-finasteride syndrome, and subsequently developing therapies for this devastating condition that is devastating the lives of thousands of men the world over.

Is it just me or does it seem that Merck has really cleaned its act up recently? You are right PR - they have one more thing they need to do to clean their dirty laundry. We are waiting…

Yes, Merck seems to be inching toward possessing the sensibilities of a responsible corporation, as opposed to the Nazi death camp it became in the late '90s.

But Kenneth Frazier still has a long way to go in terms of redeeming the company.

An excellent step in that direction would be to stop insisting finasteride is “safe for its intended use.”

Unless, of course, that intended use includes devastating the lives of thousands and thousands of men who take the prescription medication.

We’ve put a ton of pressure on them since our Media Onslaught last summer. So much that it could’ve been a factor in their Media Relations man resigning from the company.

We have to make it in their best interest to help Propecia victims, or else they’ll continue the head in the sand “response.” That means there’s only one thing left for us to do: Launch another Media Onslaught.

You may be right, SA.

I see that Ron Rogers has quietly exited Merck for (apparently) less lucrative pastures. Perhaps his conscience got to him and he could no longer work for a company with a history of not only manufacturing pharmaceutical products that cripple, castrate and kill (read: Voixx and Propecia–and perhaps even Januvia), but insist that such products are perfectly safe.

Meanwhile, I don’t see that Merck has announced a replacement yet for Rogers. But whoever that individual is, I hope he isn’t bothered by having blood on his hands (read: is a textbook psychopath).